# Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus

> **NCT01581840** · PHASE1,PHASE2 · COMPLETED · sponsor: **Federation Francophone de Cancerologie Digestive** · enrollment: 45 (actual)

## Conditions studied

- Epidermoid Carcinoma
- Anus

## Interventions

- **DRUG:** radiochemotherapy
- **DRUG:** Panitumumab

## Key facts

- **NCT ID:** NCT01581840
- **Lead sponsor:** Federation Francophone de Cancerologie Digestive
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-09
- **Final completion:** 2021-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01581840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01581840, "Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01581840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*